Skip to main content
Midas Edge

BIO-PATH HOLDINGS, INC.

For the period ended Dec 31, 2024. Filed Mar 27, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 27, 2025

BPTH$0.21-66.8%Stored close · as of Feb 18, 2025

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Shareholders’ Equity

(in thousands)

​​​​​​​​​​​​​​​
​ · ​ · ​ · ​ · Additional · ​ · ​ · ​ · ​
​ · ​ · Common Stock · ​ · Paid in · ​ · Accumulated · ​ · ​
Description · Shares · Amount · Capital · Deficit · Total
​ · ​ · ​ · ​ · ​
Balance at December 31, 2022398​$1​$105,702​$(91,529)​$14,174
​​​​​​​​​
Issuance of common stock and warrants, net of fees and warrant liability175​—​491​—​491
Exercise of warrants, net of fees​45​​—​​1,120​​—​​1,120
Stock-based compensation—​—​734​—​734
Net loss—​—​—​(16,078)​(16,078)
​​​​​​​​
Balance at December 31, 2023618​$1​$108,047​$(107,607)​$441
​​​​​​​​​​​​​​​
​​​​​​​
Balance at December 31, 2023618​$1​$108,047​$(107,607)​$441
​​​​​​​​
Issuance of common stock and warrants, net of fees and warrant liability5,150​5​9,036​—​9,041
Stock-based compensation—​—​566​—​566
Net loss—​—​—​(9,894)​(9,894)
​​​​​​​​
Balance at December 31, 20245,768​$6​$117,649​$(117,501)​$154

Bio-Path Holdings, Inc.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.